150 related articles for article (PubMed ID: 16638325)
1. [Inoculation of the cells transfected with IP10 inhibited experimental tumor metastases in vivo].
Yang XL; Chu YW; Xu L; Li BH; Xiong SD
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(3):176-81. PubMed ID: 16638325
[TBL] [Abstract][Full Text] [Related]
2. [Antitumor and antimetastatic activities of plasmid pcDNA3. 1-IP10 complexed with cationic liposome in mice with 4T1 breast cancer].
Tang QQ; Shi W; Lü HM; Peng XC; Wen YJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):195-8. PubMed ID: 19462888
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with IFN-inducible T cell alpha chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells.
Yang X; Chu Y; Wang Y; Guo Q; Xiong S
Vaccine; 2006 Apr; 24(15):2966-74. PubMed ID: 16503368
[TBL] [Abstract][Full Text] [Related]
4. Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma.
Morecki S; Yacovlev E; Gelfand Y; Uzi I; Slavin S
J Immunother; 2001; 24(2):114-21. PubMed ID: 11265768
[TBL] [Abstract][Full Text] [Related]
5. Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases.
Lewis JD; Shearer MH; Kennedy RC; Bright RK
Cancer Res; 2005 Apr; 65(7):2938-46. PubMed ID: 15805297
[TBL] [Abstract][Full Text] [Related]
6. Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model.
Mathenge EG; Dean CA; Clements D; Vaghar-Kashani A; Photopoulos S; Coyle KM; Giacomantonio M; Malueth B; Nunokawa A; Jordan J; Lewis JD; Gujar SA; Marcato P; Lee PW; Giacomantonio CA
Neoplasia; 2014 Nov; 16(11):950-60. PubMed ID: 25425969
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a DNA vaccine against extracellular domain 1-3 of Flk1 and its inhibitory effect on growth of liver cancer cell line H22].
Lu F; Qin ZY; Li YM; Qi YX; Liu YF; Yang WB
Ai Zheng; 2004 Dec; 23(12):1616-21. PubMed ID: 15601548
[TBL] [Abstract][Full Text] [Related]
8. Microenvironment of the murine mammary carcinoma 4T1: endogenous IFN-gamma affects tumor phenotype, growth, and metastasis.
duPre' SA; Redelman D; Hunter KW
Exp Mol Pathol; 2008 Dec; 85(3):174-88. PubMed ID: 18929358
[TBL] [Abstract][Full Text] [Related]
9. Biological features of core networks that result from a high-fat diet in hepatic and pulmonary tissues in mammary tumour-bearing, obesity-resistant mice.
Kim EJ; Oh HY; Heo HS; Hong JE; Jung SJ; Lee KW; Park JH; Hur CG; Park JH
Br J Nutr; 2013 Jul; 110(2):241-55. PubMed ID: 23234678
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
Pulaski BA; Smyth MJ; Ostrand-Rosenberg S
Cancer Res; 2002 Aug; 62(15):4406-12. PubMed ID: 12154047
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
[TBL] [Abstract][Full Text] [Related]
12. SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice.
Hamilton MJ; Halvorsen EC; LePard NE; Bosiljcic M; Ho VW; Lam V; Banáth J; Bennewith KL; Krystal G
Oncotarget; 2016 Jan; 7(4):3677-91. PubMed ID: 26683227
[TBL] [Abstract][Full Text] [Related]
13. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
[TBL] [Abstract][Full Text] [Related]
14. Platelet deficiency in Tpo
Thiele W; Rothley M; Dimmler A; Bugert P; Salomó Coll C; Sleeman JP
Clin Exp Metastasis; 2018 Oct; 35(7):679-689. PubMed ID: 30043083
[TBL] [Abstract][Full Text] [Related]
15. Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer.
Ahmed A; Wang JH; Redmond HP
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S389-96. PubMed ID: 22890596
[TBL] [Abstract][Full Text] [Related]
16. [Active immunity for anti-colorectal cancer induced by chemokine MCP-3 gene transfection].
Hu JY; Li GC; Zhu JG; Wang WM; Li YH; Zhou GH; Sun QB
Ai Zheng; 2002 May; 21(5):504-8. PubMed ID: 12452041
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells.
Jovanovic IP; Pejnovic NN; Radosavljevic GD; Pantic JM; Milovanovic MZ; Arsenijevic NN; Lukic ML
Int J Cancer; 2014 Apr; 134(7):1669-82. PubMed ID: 24105680
[TBL] [Abstract][Full Text] [Related]
18. Integrating individual functional moieties of CXCL10 and CXCL11 into a novel chimeric chemokine leads to synergistic antitumor effects: a strategy for chemokine-based multi-target-directed cancer therapy.
Wang P; Yang X; Xu W; Li K; Chu Y; Xiong S
Cancer Immunol Immunother; 2010 Nov; 59(11):1715-26. PubMed ID: 20706716
[TBL] [Abstract][Full Text] [Related]
19. Active immunotherapy with transiently transfected cytokine-secreting tumor cells inhibits breast cancer metastases in tumor-bearing animals.
Coveney E; Clary B; Iacobucci M; Philip R; Lyerly K
Surgery; 1996 Aug; 120(2):265-72; discussion 272-3. PubMed ID: 8751592
[TBL] [Abstract][Full Text] [Related]
20. Targeted in vivo expression of IFN-gamma-inducible protein 10 induces specific antitumor activity.
Yang X; Chu Y; Wang Y; Zhang R; Xiong S
J Leukoc Biol; 2006 Dec; 80(6):1434-44. PubMed ID: 16980511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
